Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis



Status:Enrolling by invitation
Conditions:Colitis, Colitis, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:5 - 18
Updated:3/10/2019
Start Date:November 26, 2015
End Date:March 16, 2026

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Ulcerative Colitis Who Completed the Study M11-290

This study assesses the long-term safety and efficacy of adalimumab in pediatric subjects
with ulcerative colitis.


Inclusion Criteria:

- Subject must have successfully enrolled and completed M11-290 study

Exclusion Criteria:

- Subject considered by the investigator, for any reason, to be an unsuitable candidate
We found this trial at
5
sites
Minnesota Gastroenterology, P.A. /ID# 147294
Minneapolis, Minnesota 55413
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Kurume University Hospital /ID# 145710
Kurume-shi, Fukuoka 83000
?
mi
from
Kurume-shi,
Click here to add this to my saved trials
Arnold Palmer Hosp Children /ID# 147295
Orlando, Florida 32806
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Mayo Clinic - Rochester /ID# 147304
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
MultiCare Institute Health Sys /ID# 169005
Tacoma, Washington 98405
?
mi
from
Tacoma, WA
Click here to add this to my saved trials